Cláudia Miranda

552 total citations
15 papers, 411 citations indexed

About

Cláudia Miranda is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Cláudia Miranda has authored 15 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Cláudia Miranda's work include Cancer-related Molecular Pathways (4 papers), interferon and immune responses (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Cláudia Miranda is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), interferon and immune responses (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Cláudia Miranda collaborates with scholars based in Italy, United States and France. Cláudia Miranda's co-authors include Angela Greco, Marco A. Pierotti, Emanuela Roccato, Sonia Pagliardini, Gabriella Sozzi, Claudia Miele, Emmanuel Van Obberghen, Cristina Mariani, Elena Tamborini and Maria Grazia Borrello and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and British Journal of Cancer.

In The Last Decade

Cláudia Miranda

15 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cláudia Miranda Italy	11	223	143	92	72	52	15	411
Dao Doan United States	7	250 1.1×	179 1.3×	117 1.3×	71 1.0×	67 1.3×	11	437
Xiukun Hou China	10	297 1.3×	150 1.0×	90 1.0×	83 1.2×	139 2.7×	26	483
Veronika Mančíková Spain	11	143 0.6×	127 0.9×	117 1.3×	26 0.4×	103 2.0×	15	336
Maithao Le United States	12	231 1.0×	175 1.2×	26 0.3×	56 0.8×	46 0.9×	22	466
Carla Visciano Italy	5	195 0.9×	149 1.0×	99 1.1×	53 0.7×	65 1.3×	5	447
Manuela Kohler Germany	9	164 0.7×	173 1.2×	24 0.3×	47 0.7×	34 0.7×	11	342
Yi Hong China	13	217 1.0×	101 0.7×	18 0.2×	55 0.8×	42 0.8×	18	344
Debra E. Rugowski United States	11	171 0.8×	284 2.0×	79 0.9×	43 0.6×	86 1.7×	15	435
Cláudia C. Faria Portugal	13	206 0.9×	60 0.4×	37 0.4×	40 0.6×	81 1.6×	42	429
Órla T. Cox Ireland	12	215 1.0×	52 0.4×	35 0.4×	41 0.6×	59 1.1×	14	391

Countries citing papers authored by Cláudia Miranda

Since Specialization

Citations

This map shows the geographic impact of Cláudia Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cláudia Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cláudia Miranda more than expected).

Fields of papers citing papers by Cláudia Miranda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cláudia Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cláudia Miranda. The network helps show where Cláudia Miranda may publish in the future.

Co-authorship network of co-authors of Cláudia Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Cláudia Miranda. A scholar is included among the top collaborators of Cláudia Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cláudia Miranda. Cláudia Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Miranda, Cláudia, et al.. (2023). The role of mifepristone on first trimester miscarriage treatment – A double-blind randomized controlled trial – MiFirsT. European Journal of Obstetrics & Gynecology and Reproductive Biology. 289. 145–151. 3 indexed citations

Pinheiro, Nathália M., Cláudia Miranda, Fernanda Paula Roncon Santana, et al.. (2020). Effects of VAChT reduction and α7nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation. European Journal of Pharmacology. 882. 173239–173239. 12 indexed citations

Miranda, Cláudia, et al.. (2017). Oropharyngeal histoplasmosis: The diagnosis lies in the biopsy. IDCases. 11. 33–35. 7 indexed citations

Tuccitto, Alessandra, Marcella Tazzari, Francesca Rini, et al.. (2016). Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells. Stem Cells. 34(10). 2449–2460. 18 indexed citations

Duma, Narjust, et al.. (2015). Bone Marrow Involvementas the Initial Presentation of Breast Cancer. American Journal of Medical Case Reports. 3(6). 177–180. 1 indexed citations

Conca, Elena, Cláudia Miranda, Valentina Dal Col, et al.. (2013). Are two better than one? A novel double‐mutant KIT in GIST that responds to Imatinib. Molecular Oncology. 7(4). 756–762. 16 indexed citations

Greco, Angela, Cláudia Miranda, & Marco A. Pierotti. (2009). Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Molecular and Cellular Endocrinology. 321(1). 44–49. 138 indexed citations

Miranda, Cláudia, et al.. (2007). Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. Oncogene. 26(36). 5247–5257. 30 indexed citations

Miranda, Cláudia, et al.. (2006). The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF‐κB pathway. Journal of Cellular Physiology. 208(1). 154–160. 41 indexed citations

10.

Roccato, Emanuela, et al.. (2004). Analysis of SHP-1-mediated Down-regulation of the TRK-T3 Oncoprotein Identifies Trk-fused Gene (TFG) as a Novel SHP-1-interacting Protein. Journal of Biological Chemistry. 280(5). 3382–3389. 17 indexed citations

11.

Roccato, Emanuela, et al.. (2002). Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc. British Journal of Cancer. 87(6). 645–653. 23 indexed citations

12.

Miranda, Cláudia, Angela Greco, Claudia Miele, Marco A. Pierotti, & Emmanuel Van Obberghen. (2000). IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1. Journal of Cellular Physiology. 186(1). 35–46. 41 indexed citations

13.

Greco, Angela, Cláudia Miranda, Sonia Pagliardini, et al.. (1997). Chromosome I rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid‐specific TRK oncogenes. Genes Chromosomes and Cancer. 19(2). 112–123. 1 indexed citations

14.

Pierotti, Marco A., Italia Bongarzone, Maria Grazia Borrello, et al.. (1995). Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. Journal of Endocrinological Investigation. 18(2). 130–133. 46 indexed citations

15.

Miranda, Cláudia, Fabiola Minoletti, Angela Greco, Gabriella Sozzi, & Marco A. Pierotti. (1994). Refined Localization of the Human TPR Gene to Chromosome 1q25 by in Situ Hybridization. Genomics. 23(3). 714–715. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact